EAM
LAB icon

EverPoint Asset Management’s Standard BioTools LAB Stock Holding History

EverPoint Asset Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-230,000
Closed -$1.84M – 475
2016
Q3 		$1.84M Buy
+230,000
New +$2.11M 0.03% 349
2015
Q4 		– Sell
-900,000
Closed -$7.3M – 499
2015
Q3 		$7.3M Buy
900,000
+300,000
+50% +$4.72M 0.19% 162
2015
Q2 		$14.5M Buy
+600,000
New +$18.9M 0.27% 114

Other funds holding LAB

LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

EverPoint Asset Management's LAB Position: Q4 2016 in Review

EverPoint Asset Management sold out of Standard BioTools (LAB) in Q4 2016, closing a stake of 230,000 shares — an estimated $1.84M sold.

EverPoint Asset Management first reported a position in LAB in Q2 2015 and held it in 3 quarters. The position peaked at $14.5M in Q2 2015. 83 funds tracked by Wall St. Rank hold LAB as of Q4 2016.

  • EverPoint Asset Management reported no remaining Standard BioTools position as of Q4 2016 after selling out during the quarter.
  • EverPoint Asset Management sold 230,000 Standard BioTools shares in Q4 2016, an estimated $1.84M.
  • EverPoint Asset Management first reported a position in Standard BioTools in Q2 2015 and held it in 3 quarters.
  • EverPoint Asset Management's Standard BioTools position peaked at $14.5M in Q2 2015.
  • 83 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.